Free Trial
→ Satellite Images Spot Potential $10 Trillion Discovery (From Altimetry) (Ad)tc pixel Free NLTX Stock Alerts

Neoleukin Therapeutics (NLTX) Short Interest Ratio & Short Volume

Neoleukin Therapeutics logo
$31.26 -1.07 (-3.31%)
As of 05/7/2026
Compare

Neoleukin Therapeutics Short Interest Overview

As of November 30, 2023, Neoleukin Therapeutics (NLTX) had a short interest of 26,400 shares sold short, representing 0.35% of the public float. This marks a -4.00% decrease in short interest since the prior report. The short interest ratio (days to cover) is 1.1, meaning it would take 1.1 days of the average trading volume of 50,104 shares to cover all short positions.

Current Short Interest
26,400 shares
Previous Short Interest
27,500 shares
Change Vs. Previous Month
-4.00%
Dollar Volume Sold Short
$91.34 thousand
Short Interest Ratio
1.1 Days to Cover
Last Record Date
November 30, 2023
Outstanding Shares
9,398,000 shares
Float Size
7,440,000 shares
Short Percent of Float
0.35%
Today's Trading Volume
152,690 shares
Average Trading Volume
50,104 shares
Today's Volume Vs. Average
305%
Short Selling Neoleukin Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Neoleukin Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

NLTX Short Interest Over Time

NLTX Days to Cover Over Time

NLTX Percentage of Float Shorted Over Time

Neoleukin Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/30/202326,400 shares $91.34 thousand -4.0%0.4%1.1 $3.46
11/15/202327,500 shares $94.88 thousand -20.1%0.4%1.2 $3.45
10/31/202334,400 shares $116.27 thousand -23.4%0.5%1 $3.38
10/15/202344,900 shares $162.09 thousand -8.0%0.6%1.1 $3.61
9/30/202348,800 shares $192.76 thousand +13.5%0.7%0.8 $3.95
9/15/202343,000 shares $161.25 thousand -63.5%0.1%0.7 $3.75
8/31/2023117,900 shares $88.78 thousand -7.9%0.3%0.4 $0.75
8/15/2023128,000 shares $85.76 thousand -28.1%0.4%0.5 $0.67
7/31/2023178,000 shares $122.82 thousand -20.1%0.5%0.8 $0.69
7/15/2023222,900 shares $196.15 thousand -1.7%0.6%1 $0.88
6/30/2023226,700 shares $188.16 thousand +7.4%0.7%1.8 $0.83
6/15/2023211,100 shares $156.21 thousand -8.1%0.6%1.3 $0.74
5/31/2023229,600 shares $183.68 thousand -7.5%0.7%0.6 $0.80
5/15/2023248,300 shares $214.78 thousand -18.5%0.7%0.6 $0.87
4/30/2023304,700 shares $272.52 thousand -15.7%0.8%0.7 $0.89
4/15/2023361,400 shares $285.51 thousand -37.7%1.0%0.9 $0.79
3/31/2023580,000 shares $406 thousand -0.7%1.7%1.5 $0.70
3/15/2023584,100 shares $362.14 thousand +143.8%1.7%1.4 $0.62
2/28/2023239,600 shares $120.64 thousand -26.4%0.7%0.6 $0.50
2/15/2023325,400 shares $191.99 thousand +26.1%1.0%1.4 $0.59
1/31/2023258,100 shares $153.60 thousand +9.8%0.8%0.9 $0.60
1/15/2023235,000 shares $137.19 thousand -14.8%0.7%0.8 $0.58
12/30/2022275,800 shares $140.38 thousand -31.3%0.8%1 $0.51
12/15/2022401,600 shares $181.76 thousand -26.2%1.2%1.6 $0.45
11/30/2022543,800 shares $277.34 thousand +14.6%1.6%3 $0.51
11/15/2022474,500 shares $201.57 thousand +21.1%1.4%2.6 $0.42
10/31/2022391,700 shares $222.64 thousand +10.6%1.2%1.8 $0.57
10/15/2022354,300 shares $209.60 thousand -5.2%1.1%1.6 $0.59
9/30/2022373,800 shares $239.23 thousand -30.1%1.1%1.6 $0.64
9/15/2022534,700 shares $540.05 thousand -27.2%1.6%1.7 $1.01
8/31/2022734,500 shares $756.54 thousand -35.6%2.2%2.2 $1.03
8/15/20221,140,000 shares $1.35 million +17.7%3.4%3.1 $1.18
7/31/2022968,300 shares $977.98 thousand -6.0%2.9%3.1 $1.01
7/15/20221,030,000 shares $1.11 million -2.8%3.1%3.2 $1.08
6/30/20221,060,000 shares $1.09 million -52.5%3.2%2.9 $1.03
6/15/20222,230,000 shares $2.17 million -0.5%6.7%5.8 $0.97
5/31/20222,240,000 shares $2.24 million +6.2%6.7%7.1 $1.00
5/15/20222,110,000 shares $2.07 million +11.1%6.3%7.4 $0.98
4/30/20221,900,000 shares $2.32 million +22.6%5.7%7.2 $1.22
4/15/20221,550,000 shares $2.14 million +2.0%4.6%5.7 $1.38
3/31/20221,520,000 shares $2.86 million +8.6%4.6%6.4 $1.88
3/15/20221,400,000 shares $2.63 million +2.9%4.2%6.4 $1.88
2/28/20221,360,000 shares $3.51 million +7.9%4.1%6.8 $2.58
2/15/20221,260,000 shares $3.68 million +9.6%3.8%5.7 $2.92
1/31/20221,150,000 shares $4.11 million +23.3%3.7%4.9 $3.57
1/15/2022932,400 shares $3.57 million +21.6%2.9%4.4 $3.83
12/31/2021767,000 shares $3.70 million +3.7%2.3%4 $4.82
12/15/2021739,600 shares $3.62 million -14.8%2.3%4.2 $4.90
11/30/2021867,800 shares $4.65 million +3.8%2.7%4.7 $5.36
11/15/2021836,100 shares $5.24 million -47.4%2.6%4.2 $6.27
10/29/20211,590,000 shares $11.65 million +4.6%4.9%9 $7.33
10/15/20211,520,000 shares $10.97 million -9.0%4.6%7.8 $7.22
9/30/20211,670,000 shares $12.07 million -15.7%5.1%8.5 $7.23
9/15/20211,980,000 shares $15.92 million +4.8%6.0%9 $8.04
8/31/20211,890,000 shares $15.40 million -6.9%5.8%8.6 $8.15
8/13/20212,030,000 shares $13.82 million -2.9%6.2%10.8 $6.81
7/30/20212,090,000 shares $14.61 million +1.5%6.4%11.1 $6.99
7/15/20212,060,000 shares $17.22 million No Change6.3%11.7 $8.36
6/30/20212,060,000 shares $19.01 million -21.4%6.3%11.3 $9.23
6/15/20212,620,000 shares $26.83 million -4.7%8.0%14.5 $10.24
5/28/20212,750,000 shares $27.58 million -5.5%8.4%14.6 $10.03
5/14/20212,910,000 shares $30.23 million +2.5%N/A15.6 $10.39

NLTX Short Interest - Frequently Asked Questions

Short interest is the volume of Neoleukin Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 26,400 shares of NLTX short. 0.35% of Neoleukin Therapeutics' shares are currently sold short. Learn More on Neoleukin Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NLTX shares currently have a short interest ratio of 1.1. Learn More on Neoleukin Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.35% of Neoleukin Therapeutics' floating shares are currently sold short.

Neoleukin Therapeutics saw a decrease in short interest in the month of November. As of November 30th, there was short interest totaling 26,400 shares, a decrease of 4.0% from the previous total of 27,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Neoleukin Therapeutics currently has issued a total of 9,398,000 shares. Some of Neoleukin Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Neoleukin Therapeutics currently has a public float of 7,440,000 shares.

0.35% of Neoleukin Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Neoleukin Therapeutics: DBV Technologies S.A. (0.11%), Septerna, Inc. (5.72%), Savara Inc. (14.26%), Xeris Biopharma Holdings, Inc. (9.76%), Alvotech (0.90%), CureVac N.V. (0.44%), Amphastar Pharmaceuticals, Inc. (12.09%), Phathom Pharmaceuticals, Inc. (13.20%), Oric Pharmaceuticals, Inc. (22.18%), Maravai LifeSciences Holdings, Inc. (3.67%),

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Corporation ($6.17 billion), Canadian Natural Resources Limited ($3.99 billion), T-Mobile US, Inc. ($3.78 billion), Charter Communications, Inc. ($3.37 billion), Coinbase Global, Inc. ($2.89 billion), Suncor Energy Inc. ($2.83 billion), Occidental Petroleum Corporation ($2.64 billion), Tractor Supply Company ($2.31 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Rivian Automotive, Inc. ($1.71 billion). View all of the most shorted stocks.

Short selling NLTX is an investing strategy that aims to generate trading profit from Neoleukin Therapeutics as its price is falling. NLTX shares are trading down $1.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Neoleukin Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NLTX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NLTX, twice per month. The most recent reporting period available is November, 30 2023.

Understanding short interest metrics can help you assess how traders are positioning around a stock like NLTX:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:NLTX) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners
The Death of the Nasdaq?
The Death of the Nasdaq? Wall Street legend Marc Chaikin's award-winning system turned bearish on software ...
Chaikin Analytics | Sponsoredtc pixel
One executive order. The biggest wealth transfer of your lifetime.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
The Iran War Just Broke the Gold Market
The Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged...
Behind the Markets | Sponsoredtc pixel
JPMorgan Just Made $6,300 Gold Call. Are You Exposed?
JPMorgan just raised its 2026 gold forecast to 6,300 - and outlined a credible path to 8,000 if everyday inves...
Vault Metal | Sponsoredtc pixel